Ionis Pharmaceuticals Inc
(STU:ISI)
€
34.62
0.13 (0.38%)
Market Cap: 5.44 Bil
Enterprise Value: 4.45 Bil
PE Ratio: 0
PB Ratio: 8.55
GF Score: 59/100 Ionis Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 07, 2022 / 02:10PM GMT
Release Date Price:
€29.21
(-1.72%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Okay. Well, Good morning, everybody, and thank you once again for joining us for the 42nd Annual Healthcare Conference at Cowen. I'm Yaron Werber from the biotech team. And it's a great pleasure to moderate the orphan neurology panel with my colleagues, Brendan Smith and Eva Privitera. We really have a terrific session today. We have with us Shoshana Shendelman, who is the Founder and CEO of Applied Therapeutics; Brett Monia, who is the CEO of Ionis; Jeremy Levin, who's the CEO of Ovid; and Ed Kaye from Stoke. Gentlemen and ladies, thank you so much for joining us. Great to see you.
Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director
Thanks, Yaron.
Edward M. Kaye
Stoke Therapeutics, Inc. - CEO & Director
Thank you.
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
So we have a lot to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot